Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Incoming HIV virion-derivedGag Spacer Peptide 2 (p1) is a targetof effective CD8+T cell antiviral responses
Absence of drug-drug interactions between γ-hydroxybutyric acid (GHB) and cobicistat.
Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection.
Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy.
Novel Approaches Towards a Functional Cure of HIV/AIDS.
Does Antigen Glycosylation Impact the HIV-Specific T Cell Immunity?
Immune Profiles Identification by Vaccinomics After MVA Immunization in Randomized Clinical Study.
Correction to: Novel Approaches Towards a Functional Cure of HIV/AIDS.
HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02).
Pharmacokinetic/pharmacodynamic analysis of romidepsin used as an HIV latency reversing agent.